logo
Grey's Anatomy's Eric Dane reveals ALS fight — spot the early signs before it's too late

Grey's Anatomy's Eric Dane reveals ALS fight — spot the early signs before it's too late

Time of India28-06-2025
Actor Eric Dane disclosed his ALS diagnosis. ALS is a motor neuron disease impacting muscle control. Early diagnosis is crucial for slowing its progression. Symptoms can mimic other nerve issues. Tests help confirm ALS. While there's no cure, treatments manage symptoms. Riluzole and Edaravone may help. Physical, speech, and breathing therapies aid patients.
Tired of too many ads?
Remove Ads
What is Amyotrophic Lateral Sclerosis?
Tired of too many ads?
Remove Ads
Can ALS be treated?
FAQs
Grey's Anatomy star Eric Dane, recently confessed to being suffering from ALS. The actor claimed it all started with a tinge in his right hand, but shrugged it off thinking it's numbness.Dr. P R Ranjen, a neurologist for Apollo Hospitals , said that he himself mistook an ALS of a 60-year-old patient in his right palm as a routine nerve irritant, the Indian Express said.But the patient later lost full function of his right arm, couldn't swim, and had fast muscle loss. Dr. Renjen said early diagnosis is key, because starting treatment early can help slow the disease.He warned that ALS symptoms often look like other nerve problems, so it's easy to misdiagnose or delay treatment. He advised that anyone with nerve complaints or even muscle flickering should go see a neurologist immediately, as stated in the report by The Indian Express.A motor neuron disease, ALS, wrecks the nerves that control muscle movements. It hampers the signals sent by the brain to the muscles, causing a lingering muscle pain and over time severely damaging movements like swallowing and breathing, reports said.Mostly impacting people between ages of 45 to 70 years. However, it can rarely also happen to juveniles in the form of motor neuron disease. No particular reason has been ascertained to itA small number of cases are genetic, passed from a parent. It's a rare disease — only about 5 people in every 100,000 in India get ALS. It's seen more in men than in women, as per the report by The Indian Express.Diagnosis is very important, because some similar problems can be treated and cured, unlike ALS.Tests like nerve conduction test and electromyography help confirm if it's ALS.There is no cure yet for ALS. But doctors can help manage the symptoms and slow down the disease. Medicines like Riluzole and Edaravone can help slow down disease progression and increase survival time, as per reports.Physical therapy can help keep muscles working longer. Speech therapy becomes helpful when talking or swallowing gets tough. As breathing weakens, special breathing machines can support patients. Things like wheelchairs, communication tools, and feeding tubes can help people stay independent, according to the report by The Indian Express.Emotional and mental health support is also very important — both for the person with ALS and their family or caregivers. Many ALS patients show amazing strength and courage, even as they face this tough journey, as stated by reports.Eric Dane revealed he is battling ALS, a serious nerve disease.Amyotrophic Lateral Sclerosis (ALS) is a disease that weakens the nerves that control your muscles. Over time, it affects movement, speech, swallowing, and even breathing.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This ‘fake' cardiologist's last 5 patients died on the SAME DAY! Who is Dr John Camm?
This ‘fake' cardiologist's last 5 patients died on the SAME DAY! Who is Dr John Camm?

Mint

time11 hours ago

  • Mint

This ‘fake' cardiologist's last 5 patients died on the SAME DAY! Who is Dr John Camm?

The last five patients of Narendra Vikramaditya Yadav, a fake cardiologist posing as 'Dr John Camm' died on the same day that he operated on them, Indian Express has reported. Yadav posed as 'Dr John Camm', a top UK-based heart specialist, and has been accused of performing medical procedures without valid licence. The accused, as per inspection records presented before the Madhya Pradesh assembly, was performing crucial angioplasty operations under a false identity. The fake cardiologist performed 12 such operations at Mission Hospital in Damoh district between January 2 and February 11. As per sources quoted by The Indian Express, five of these patients died during the same day as the angioplasty — two during the procedure and three soon after it. The five patients 'treated' by Yadav, aged between 51 and 75, died one after the other in a span of just one month, the state assembly was informed. The death of these patients has raised serious questions about how the fake cardiologist was hired and allowed to conduct operations without proper supervision. The newspaper further stated in its report that Yadav fled after operating on his last patient and resigned from the hospital, taking a portable echo machine with him. The five patients who died on the same day after being operated on by Yadav include: Raheesa Begum (63) — treated on January 15 Israel Khan (75) — treated on January 17 Buddha Ahirwar (67) — treated on January 25 Mangal Singh Rajput (65) — treated on February 2 Satyendra Singh Rathore (51) — treated on February 11 Deputy chief minister Rajendra Shukla on Friday told the MP assembly that he hospital had failed to inform health authorities about Yadav's appointment, violating provisions under Madhya Pradesh Nursing Homes and Clinical Establishments (Registration and Licensing) Act. The government, therefore, had no scope to verify Yadav's credentials and the authenticity of his medial profession claims. The fake cardiologist is now under judicial custody, after being arrested in April this year. The charges Yadav is facing include fraud, impersonation, and culpable homicide among others.

Elon Musk's Neuralink partners with UK hospitals to test brain chips
Elon Musk's Neuralink partners with UK hospitals to test brain chips

Hindustan Times

time12 hours ago

  • Hindustan Times

Elon Musk's Neuralink partners with UK hospitals to test brain chips

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.(Reuters) The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X. Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study. Also read: Elon Musk reacts as Neuralink recipient writes her name using only thoughts after 20 years: 'This is possible' The company raised $650 million in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the U.S. Food and Drug Administration, which had initially rejected Neuralink's application in 2022. According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts. Neuralink, founded in 2016, has raised about $1.3 billion from investors and is valued at roughly $9 billion, according to media reports, citing PitchBook.

Musk's Neuralink to test brain chips in clinical study in Great Britain
Musk's Neuralink to test brain chips in clinical study in Great Britain

Time of India

time14 hours ago

  • Time of India

Musk's Neuralink to test brain chips in clinical study in Great Britain

Bengaluru: Elon Musk 's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts. The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X. Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study. The company raised $650 million in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the U.S. Food and Drug Administration, which had initially rejected Neuralink's application in 2022. According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store